If the public interest is at the core of the FDA's mission, it needs to move quickly and promulgate rules that will facilitate market entry, heighten industry price competition, save consumers money, and produce better patient outcomes.
Now, when there are some very real and very serious anti-American actions being asked for, Dimon is strangely silent. Could it be because the current anti-American requests coincide with his claims against financial reform? Of course it is.
It is past time for the president to let his actions speak for him and they will speak louder than any of his words. That is what the American people are waiting for. That is also what the banks, Wall Street and their allies fear most.
The presumption that we've got lots of useless regulation in place plays off of years of conservative rhetoric about how regulatory red tape is choking American business. But this idea is divorced from reality.